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LETTER TO THE EDITOR
Breast cancer and the pill
Sir - In their recent paper Kay & Hannaford (1988)
tentatively concluded that oral contraceptive use 'before the
first term birth may be associated with an increased rate of
presentation of breast cancer in women under the age of 35
years'. They point out that studies designed to explore the
association between breast cancer and oral contraceptive use
have produced inconsistent results and are rightly cautious in
their overall interpretation of their study findings. When
different studies of the same subject produce conflicting
results, it is essential to evaluate each study critically in order
to ascertain how the conflicts might have arisen. Kay and
Hannaford's study has several problems which may invali-
date even the most tentative of conclusions.
The study is based on a cohort recruited in 1968-69 of
about 23,000 women, who were then current users of oral
contraceptives, and a similar number of women who were
not using oral contraceptives. The patients were recruited
through a network of research orientated general practi-
tioners. In an earlier paper (Royal College of General
Practitioners, 1974) the advantages of involving the general
practitioners in this way were explained; it was said that it
would enable the investigators to obtain complete data and
that it would facilitate follow-up. In view of the latter claim
it is disappointing that by March 1985 (17 years), only
18,000 (38.3%) of the original 47,000 women were still under
observation. This represents an average loss to follow-up of
3.6% per year. Moreover, from their Table I the study so far
has yielded 406,836 woman years of experience - this is an
average of 8.66 years per woman or just over 50% of what
was theoretically possible. No information is given about the
women lost to follow-up nor is there any explanation of the
loss. It is possible that the women lost to follow-up were so
different from those who were not as to invalidate the
analyses.
The breast cancer rates quoted were standardised for 'age
and parity at the time of diagnosis and daily cigarette
consumption and social class at recruitment'. Presumably
this procedure was adopted in order to eliminate the effects
of important confounding variables. The authors accept that
age of mother at first birth is an important determinant of
breast cancer risk but they did not foresee the need to collect
this piece of information when the study was designed. Their
justification for adopting parity as a proxy for age at first
pregnancy is that Macmahon et al. (1970) showed that parity
was correlated with age at first pregnancy. Macmahon et
al.'s work was undertaken in the 1960s, mostly before the
patients were recruited to the Kay & Hannaford study, and
was concerned with residents of North America. It is
unlikely that the correlation between age of first pregnancy
and parity that they noted has been sustained following the
introduction of modern contraceptives and even more un-
likely that the patterns of family building observed in the
USA in the 1950s and 1960s could be applied to UK women
in the 1970s. The authors' contention that 'the effects of any
differences in the age at first birth between groups should be
reduced by standardisation for parity' cannot be sustained
on the information that is offered.
From a number of case-control studies there is evidence
that breast cancer risk is associated with smoking. It is
therefore reasonable to attempt to adjust the rates for
variations in smoking habits when exploring the relationship
between oral contraceptive use and breast cancer. However,
it is questionable whether the daily consumption of cigarettes
at recruitment to the cohort should form the adjustment. In
the intervening 17 years it is possible that the smoking habits
of the women studied varied considerably, particularly as the
smoking habits of women may well change because of
pregnancy. There is no a priori reason to suppose that the
interval between exposure to tobacco and the occurrence of
breast cancer is such that this single historical measure
should be appropriate.
The standardisation for social class measured at the time
of recruitment to the cohort presents similar problems to
those of cigarette smoking. It has been established that there
is an association between carcinoma of the breast and social
class at the time of diagnosis. It is unlikely that the social
class distribution of a group of women will be sufficiently
stable over 17 years to justify using the social class at
recruitment to the study as a proxy for social class at
diagnosis.
The use of exposed and non-exposed woman years as the
main denominator in many of the analyses makes it difficult
to establish how many different women were in the sub-
categories described, but it is possible to highlight an
important anomaly. Table III of Kay & Hannaford's paper
sets out breast cancer risk by parity in ever users and
controls, and the risk ratios (after standardisation for age at
diagnosis and social class and smoking habit at recruitment).
The risk ratio is computed by dividing the incidence rates
among the ever users by the incidence rates among the never
users (controls). This indicates a significant increase in risk
of between 2.2 and 17.1 among the ever exposed of parity 1
compared to controls of the same parity. Using the same
methodology it is clear that parity has different effects on
controls compared to the ever users (see Table).
Ever users Controls
Parity Standardised Risk ratio Standardised Risk ratio
group rate (TWY) (para 0=1) rate (TWY) (para 0=1)
0 0.42 1.00 0.37 1.00
1 0.93 2.21 0.16 0.43
2+3 0.65 1.55 0.65 1.76
4+ 0.48 1.14 0.68 1.84
Earlier in their paper the authors advanced the view that
parity is correlated with age at first birth and that parity
could therefore be used as a proxy for that important
variable. Their data show that the risk among both groups
of nulliparous women is lower than among parous women
and that the apparent slope of the risk ratio according to
parity is paradoxical between the ever users and never users.
This observation must bring into question their findings set
out in Table IV, which show an apparent increase in risk
among para I women exposed to oral contraceptives for
between 2 and 7 years and for women aged 30-34 years.
Yours etc.,
R.D.T. Farmer,
Dept. of Community Medicine,
Charing Cross and Westminster Medical School,
17 Horseferry Road,
London SWIP 2AF, UK.
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